Market Access
New Tech on the Rise: The Future of Cell and Gene Therapies Is Here
Recent headlines suggest that the biotech industry as a whole is experiencing a downturn, ...
Improving Quality of Care Via Financial Assistance Messages at the Point of Care
In 2017, the World Bank and WHO released a report, which stated that at ...
The Imperative for KAM in Pharma
Over the past decade, macro trends in healthcare have pushed life sciences companies to ...
Visualizing New Data Stories Helps Pharma Smooth Gaps in the Patient Journey
Harnessing data to present a holistic view of a patient’s individual journey can transform ...
The Inflation Reduction Act Passed, Now What?
In April 2022, we released an article describing proposed policies from the federal government ...
5 Ways Your Market Access Strategy Can Create a Better-Connected Patient Experience
Market access stands at the cusp of a golden opportunity to help increase healthcare ...
The Hidden Facts About Voucher and Bridge Pricing
The healthcare industry is rife with hidden revenue streams, specifically within the patient affordability ...
Inflationary Impact on Employer-Sponsored Health Coverage: Will a Recession be Different this Time?
Providing all Americans with access to affordable, quality healthcare is one of the most significant ...
Global Biopharma Launches in the New World Order
Biopharma blockbusters in the last 10 years show a disturbing trend. On average, they ...
It Takes a Village: How Pharma Can Help Address the Mental Health and Substance Abuse Crisis
The COVID-19 pandemic led to an increase in depression and anxiety, along with an ...
Importance of Ambulatory Surgery Centers to the Medical Device Industry
Philips, Siemens, DePuy, Boston Scientific. A simple Google search on the topic of ambulatory ...
Potential Policy Changes that Could Upend Prescription Drug Pricing
On November 3, 2021, Congress introduced a working draft of the Build Back Better ...
Roadmap to Improved Coverage and Access for Specialty Products
As specialty pharmaceutical products are becoming increasingly complex due to more technology-driven drug development, ...
